<DOC>
	<DOCNO>NCT00293228</DOCNO>
	<brief_summary>The purpose study study effect treatment dormant tuberculosis infection immunological system . We expect observe impact production cytokine peripheral white blood cell may useful know treatment effective .</brief_summary>
	<brief_title>Treatment Latent Tuberculosis Infection With Isoniazid</brief_title>
	<detailed_description>As part on-going study conduct Orizaba Health Jurisdiction southeastern Mexico , household contact pulmonary TB patient recently convert tuberculin test TST+ve contact randomly select control households history TB within last 2 year ( remote contact ) enrol . We assume individual infect Mycobacterium tuberculosis . Additional confidence subject enrol latently infect come ELISPOT analysis response ESAT-6 CFP-10 . We propose administer INH 100 TST+ve recent 100 TST+ve remote contact 6 month . To control spontaneous fluctuation biomarker level , propose defer therapy 3 month half subject group . Thus , four group define : A . Recently convert contact receive isoniazid ( 5mg per kg 300 mg daily 6 month ) immediately recruitment . B . Recently convert contact receive isoniazid ( 5mg per kg 300 mg daily 6 month ) three month recruitment . C. Remote contact receive isoniazid ( 5mg per kg 300 mg daily 6 month ) immediately recruitment . D. Remote contact receive isoniazid ( 5mg per kg 300 mg daily 6 month ) three month recruitment . All contact undergo clinical evaluation enrolment review . The development active TB trigger withdrawal full treatment . Fortnightly clinical review group B defer phase undertaken . ELISPOT analysis perform subject 0 , 1 , 4 , 13 , 26 40 week group A C , 0 , 13 , 14 , 17 , 26 , 40 54 week group B D. A subset 10 patient per group sample expression analysis 0 , 4 , 26 40 week ( group A C ) 0 , 13 , 17 40 week group B D ( 160 hybridization total ) .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Latent Tuberculosis</mesh_term>
	<mesh_term>Isoniazid</mesh_term>
	<criteria>Inclusion criterion : Informed consent Age 1045 Either sex Resident study area Documented TST+ve ( &gt; 10mm , Mantoux method , 2TU , PPD Statens Serum Institute ) Normal chest radiograph HIV negative test Exclusion criterion : Active tuberculosis Previous diagnosis tuberculosis Treatment active latent tuberculosis Contact TB patient harbor MDR INH resistant isolates Mtb Diseases therapy associate immunosuppression Diabetes mellitus Abnormal liver enzyme level . HB 8gr/dl Pregnancy ( ascertain urinary Î²HCG ) Allergy intolerance isoniazid Peripheral neuropathy Ingestion drug interact isoniazid</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Latent tuberculosis</keyword>
	<keyword>biomarkers</keyword>
	<keyword>isoniazid</keyword>
	<keyword>ELISPOT</keyword>
	<keyword>PPD positive individual</keyword>
</DOC>